A genetically modified poliovirus therapy significantly improved long-term survival for patients with recurrent glioblastoma, with a three-year survival rate of 21 percent, a new study shows. In comparison, only 4 percent of patients with the same type of recurring brain tumors were alive at three years when undergoing the previously available standard treatment. “Glioblastoma remains… Read more
For children younger than five years of age, supplementing oral vaccine with a shot of inactivated poliovirus vaccine substantially boosts intestinal immunity to the crippling poliovirus.
15 million people around the world have survived poliomyelitis, and up to 80% report progressive deteriorating strength and endurance many years after infection, a condition known as post-polio syndrome (PPS). Researchers in Italy from the National Hospital for Poliomyelitis, the Policlinico G.B. De Rossi, and the University of Milan have found that transcranial direct current… Read more